Jump to content

Our Customers.
World Leading.
Forward Thinking.

They Rely On Us.

Many of the world’s leading biopharmaceutical, agricultural, industrial biotech companies, and academic research institutions trust us with their most valuable resource - their data. Here is a sampling.

Global Top 25 Biopharma Companies

Biotechs, CGT & Vaccine Innovators

Established CROs & CDMOs

Academic & Scientific Non-Profit Organizations

Customer Stories


Enabling In-Depth MS-based Characterization of Biopharmaceuticals

Discover how Merck Serono implemented Genedata Expressionist® to develop novel and efficient MS-based methods for the analysis of charge-variants, glycoforms, and released glycans in biopharmaceuticals - resulting in time savings of up to 80% compared to conventional methods.


Pfizer Builds on the Genedata E2E Workflow Platform

Pfizer chose the Genedata platform to serve as a central data backbone and application environment upon which they could build tools to flexibly address Pfizer-specific requirements and drive innovation. Today, the system is used by over 250 people in 15 groups located at six Pfizer R&D sites globally, supporting 200+ distinct projects.


MorphoSys Accelerates Antibody R&D with Genedata Biologics

The MorphoSys adoption of Genedata Biologics® as their end-to-end workflow platform significantly increased efficiencies across all R&D functions, including library generation, screening and selection, molecular biology, antibody screening, protein engineering, expression, purification, and analytics.


High-Throughput MS-Based Screening of Bispecific Antibodies

Using Genedata Expressionist®, scientists at Genmab established an automated MS-based high-throughput assay that provides qualitative and quantitative information on a DuoBody® bsAb preparation. Compared to the CEX-based process, data acquisition and processing times were reduced by 95% and the number of person hours dedicated to data processing was reduced by 70%.

Scientific Tech Notes


Highly Scalable Transcriptomic Screening Analysis

Discover a new solution embedded within Genedata Screener® which allowed Janssen to rapidly and simultaneously analyze expression for 20 to 80 different genes per compound, measured in plate-based screens performed using the QuantiGene® RNA Assay.


Efficient & High Quality CHO Cell Line Development

This application note describes how Genedata Selector® has been used to analyze next generation sequencing (NGS) data from Cergentis' TLA technology in CHO cell line development and quality control.


End-to-End Analysis Workflow for HT Mass Screening

AstraZeneca integrated Genedata Expressionist®, an MS analysis software, to build an end-to-end HT-MS analysis workflow and Genedata Screener®, an analysis platform for in-vitro screening. These integrations enabled a 7-fold decrease in analysis time, preparing AstraZeneca to expand use of their innovative technology.


Completing End-to-End Assay Automation with Automated Data Analysis

The Genedata platform enables Roche to fully automate the analysis of lower throughput assays. They achieved end-to-end automation, including of the data analysis, allowing them to save significant time, improve data quality and result robustness.



Ready to Start Transforming Your Biopharma R&D?

Get in Touch